To date, this gain-of-function mutation, K365T has been identified in two cases of endometrioid adenocarcinoma5 and one serous carcinoma case.26 This K365T mutation is the only CTCF mutation to be identified in a worse prognosis serous subtype tumour. This evidence concerns the gene CTCF and serous adenocarcinoma.